Insulet Corp

PODD remains in a Stage 2 advancing corrective reset within its longer-term uptrend, but an active Bullish Exhaustion pattern and Extreme Overbought readings on EMAs and options score signal poor timing for immediate entries. We maintain a medium-term bullish bias but will await a pullback into the rising EMA support zone near the 9- and 20-period EMAs before engaging.

• ↑Q1 revenue reached $762 M (+30% YoY) driven by Omnipod demand
• ↑International Omnipod 5 launch drove 45% overseas sales growth
• ↓Class action alleges Omnipod safety misrepresentation, adding volatility